Inventor
Jinichi Yonemori
Inventor
Kanagawa, JP
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes22%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
C07BGeneral methods of organic chemistry11%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
10,899,7522,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor202110,548,899Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity202010,548,877Aromatic ring compound202010,435,399HDAC6 inhibitory heterocyclic compound201910,428,056Heterocyclic compound201910,323,0272,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor201910,131,653Heterocyclic compound20189,878,989'Heterocyclic compound'20188,008,525'Receptor function regulating agent'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011Patents assigned to TAKEDA PHARMACEUTICAL (1)· patent assignee history
2011Based in Osaka, JP· patent location history
2018–2021Patents assigned to TAKEDA PHARMACEUTICALS CO (8)· patent assignee history
2018–2021Based in Kanagawa, JP· patent location history
2018Based in Fujisawa, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 8 | 2018–2021 |
| TAKEDA PHARMACEUTICAL | 1 | 2011 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kanagawa, JP | 7 | 2018–2021 |
| Fujisawa, JP | 1 | 2018 |
| Osaka, JP | 1 | 2011 |